Invention Grant
- Patent Title: Method of optimizing the treatment of proliferative diseases mediated by the tyrosine kinase receptor KIT with imatinib
-
Application No.: US15297372Application Date: 2016-10-19
-
Publication No.: US09763944B2Publication Date: 2017-09-19
- Inventor: Yanfeng Wang , Elisabeth Wehrle
- Applicant: Yanfeng Wang , Elisabeth Wehrle
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Michelle Han
- Main IPC: A01N43/00
- IPC: A01N43/00 ; A61K31/33 ; A61K31/506 ; G01N33/574
Abstract:
The invention relates to a method of treating proliferative diseases mediated by the tyrosine kinase receptor KIT, in particular GIST, in a human patient population.
Public/Granted literature
Information query
IPC分类:
